サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1325098

デジタル吸入器の世界市場

Digital Dose Inhalers
出版日: | 発行: Global Industry Analysts, Inc. | ページ情報: 英文 507 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.42円
デジタル吸入器の世界市場
出版日: 2023年08月09日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 507 Pages
納期: 即日から翌営業日
● ご注意事項
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

デジタル吸入器の世界市場は2030年までに72億米ドルに達する

COVID-19後の変化したビジネス環境において、2022年に29億米ドルと推計されたデジタル吸入器の世界市場は、2030年までに72億米ドルに達すると予測され、2022-2030年の期間においてCAGR 12.1%で成長すると予測されます。本レポートで分析したセグメントの1つである定量投与は、CAGR 11.4%を記録し、分析期間終了時には44億米ドルに達すると予測されます。現在進行中のパンデミック後の回復を考慮し、ドライパウダー分野の成長は今後8年間のCAGRを13.2%に修正しました。

米国市場は12億米ドルと推計、中国はCAGR 15％で成長すると予測

米国のデジタル吸入器市場は、2022年には12億米ドルになると推定されます。世界第2位の経済大国である中国は、2022年から2030年までの分析期間においてCAGR15%で推移し、2030年までに6億6,980万米ドルの市場規模に達すると予測されています。その他の注目すべき地理的市場としては、日本とカナダがあり、2022年から2030年にかけてそれぞれ10.1%と10.7%の成長が予測されています。欧州では、ドイツがCAGR約11.6%で成長すると予測されています。

調査対象企業の例

  • Beximco Pharmaceuticals Ltd.
  • 3M Company
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Chiesi Farmaceutici SpA
  • AptarGroup, Inc.
  • Bespak Europe Ltd.
  • Berry Global, Inc.
  • BIOCORP
  • Adherium（NZ）Limited
  • Amiko Digital Health Limited
  • Aerami Therapeutics
  • Cognita Labs
  • AireHealth, LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP21630

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Digital Dose Inhalers Market to Reach $7.2 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Digital Dose Inhalers estimated at US$2.9 Billion in the year 2022, is projected to reach a revised size of US$7.2 Billion by 2030, growing at aCAGR of 12.1% over the period 2022-2030. Metered Dose, one of the segments analyzed in the report, is projected to record 11.4% CAGR and reach US$4.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Dry Powder segment is readjusted to a revised 13.2% CAGR for the next 8-year period.

The U.S. Market is Estimated at $1.2 Billion, While China is Forecast to Grow at 15% CAGR

The Digital Dose Inhalers market in the U.S. is estimated at US$1.2 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$669.8 Million by the year 2030 trailing a CAGR of 15% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 10.1% and 10.7% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.6% CAGR.

Select Competitors (Total 53 Featured) -

  • Beximco Pharmaceuticals Ltd.
  • 3M Company
  • AstraZeneca PLC
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Chiesi Farmaceutici SpA
  • AptarGroup, Inc.
  • Bespak Europe Ltd.
  • Berry Global, Inc.
  • BIOCORP
  • Adherium (NZ) Limited
  • Amiko Digital Health Limited
  • Aerami Therapeutics
  • Cognita Labs
  • AireHealth, LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Impact of COVID-19 Pandemic and Looming Global Recession; Living with COVID-19, the New Normal
    • Stagflation and Risk of Recession: New Challenges Emerge for the Global Market in 2022 & 2023
    • World Economic Growth Projections (Real GDP, Annual % Change) for the Years 2020, 2021, 2022 and 2023
    • COVID-19 Healthcare Emergency Highlights Critical Significance of Digital Dose Inhalers
    • Ongoing Studies Exploring Use of Inhalers-based Therapies to Treat COVID-19
    • COVID-19 Pandemic Pushes Patient Compliance Linked with Inhaler-based Drug Regime
    • Pandemic Accelerates Transition to pMDIs with VHCs
    • Research Shows Asthma Drug to be Effective in Treating COVID-19
    • Competitive Scenario
    • Digital Dose Inhalers - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Global Market Prospects and Outlook: High Prevalence of Respiratory Diseases Keeps Digital Dose Inhalers Market in Hale & Hearty Condition
    • World Digital Dose Inhalers Market by Application (2021 & 2027): Percentage Breakdown of Sales for Asthma, COPD, and Other Applications
    • Salient Growth Drivers
    • Analysis by Product: Metered Dose Inhalers Occupy Commanding Share
    • World Digital Dose Inhalers Market by Product (2021 & 2027): Percentage Breakdown of Sales for Metered Dose Inhalers, and Dry Powder Inhalers
    • Analysis by Type of Medication: Branded Medications Segment Hold Major Share
    • World Digital Dose Inhalers Market by Type of Medication (2021 & 2027): Percentage Breakdown of Sales for Branded, and Generic
    • Regional Analysis: North America to Retain Leadership Position in Digital Dose Inhalers Market
    • Developed Regions Account for Lion's Share of World Digital Dose Inhalers Market: Percentage Breakdown of Sales for Developed and Developing Regions (2021E & 2027P)
    • Global Market for Digital Dose Inhalers - Geographic Regions Ranked by % CAGR (Sales) for 2020-2027: China, Asia-Pacific, Latin America, Middle East, Africa, USA, Europe, Canada, and Japan
    • An Introduction to Digital Dose Inhalers - Smart Aids to Manage Dose Delivery for Respiratory Conditions
    • Digital Inhaler Health Platforms
    • Metered Dose Inhalers (MDI)
    • Dry Powder Inhalers (DPI)
    • Recent Market Activity
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Digital Inhalers: A Significant Leap Forward for Respiratory Disease Management
    • Asthma & Respiratory Management as Twin Goals for Digital Technology
    • Respiratory Care Domain Perfectly Ripe for Adoption of Digital Devices
    • Healthcare Market Enjoys Striking Leap Forward with Increasing Influx of IoT
    • Global IoT Market (In US$ Billion) by Industry for the Years 2018 and 2022
    • Number of Connected Medical Devices in Million: 2018-2025
    • Digital Dose Inhaler Technology Sees Proliferation of IoT
    • Advantages of the IoT-Enabled Digital Dose Inhaler
    • Market to Gain from Ongoing R&D Emphasis on Advanced Treatments for Pulmonary Diseases
    • Established Role of Inhaler Therapy in Respiratory Care Augurs Well
    • Growing Prevalence of Asthma Provides the Perfect Platform for Market Expansion
    • Role of Respiratory Inhalers in Asthma
    • Asthma Rescue Inhalers Medications
    • Asthma Long-Term Medications
    • Rising Prevalence of Asthma in Children Supports Growth
    • Asthma Prevalence in the US by Age
    • Asthma Prevalence in the US by Gender
    • Asthma Prevalence in the US by Race/Ethnicity
    • Slew of Smart Digital Technology & Tools for Asthma Care
    • Mounting Burden of COPD Drives Demand for Digital Dose Inhaler Technology
    • COPD Stats
    • Global Prevalence of COPD: Percentage of Men and Women Affected by Age Group
    • Prevalence Percentage of COPD, Asthma, and Allergic Rhinitis for Select Countries
    • Global Cost of Respiratory Therapy by Disease (2019): Percentage Breakdown of Therapy Costs for Asthma, Chronic Obstructive Pulmonary Disease (COPD), Idiopathic Pulmonary Fibrosis, and Others
    • Dry Powder Inhalers Set to Make Big Gains
    • Green Thumbs Up with Rising Uptake of Dry Powder Inhalers
    • Metered Dose Inhalers Continue to Exhibit Sustained Growth Momentum
    • Smart Inhalers Come to the Fore
    • Smart Inhalers Strike Right Chord with Medication Adherence Application
    • Artificial Intelligence Plays Significant Role in Automation and Improving Outcomes
    • Global Healthcare Artificial Intelligence Market by Application: 2021
    • Artificial Intelligence to Add Sophistication to Inhaler Technology
    • New HME Method to Augment Inhaler Technology
    • 3D Printing Seeks Role in Inhaler Manufacturing
    • Rise in Air Pollution Levels Trigger Demand for Respiratory Devices and Inhalers
    • Global Indoor Air Pollution Related Fatalities by Health Condition (In %) for 2020
    • World Ranking of Most Polluted Countries
    • Percentage Share Breakdown of Global Deaths Linked to Air Pollution
    • Ranking of Global Number of Deaths by Risk Factor
    • Uptrend in Healthcare Spending to Result in Improved Opportunities
    • World Healthcare Expenditure (In US$ Billion) for the Years 2017, 2019, 2021 & 2023
    • Healthcare Costs as a % of GDP by Country for the Years 2020 & 2023
    • Vulnerability of Growing Geriatric Population to Respiratory Diseases Enhances Prospects for Digital Inhalers
    • Elderly Healthcare Expenditure as a % of GDP
    • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Global Population Statistics for the 65+ Age Group by Select Countries: 2019
    • Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050)
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Digital Dose Inhalers Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Digital Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Digital Dose Inhalers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 4: World 16-Year Perspective for Digital Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2023 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Metered Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Metered Dose by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 7: World 16-Year Perspective for Metered Dose by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Dry Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Dry Powder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 10: World 16-Year Perspective for Dry Powder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Branded by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 13: World 16-Year Perspective for Branded by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Generic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 16: World 16-Year Perspective for Generic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Asthma by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 19: World 16-Year Perspective for Asthma by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 21: World Historic Review for COPD by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 22: World 16-Year Perspective for COPD by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 25: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Digital Dose Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 34: USA 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • CANADA
    • Digital Dose Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Canada for 2022 (E)
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • JAPAN
    • Digital Dose Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Japan Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 52: Japan 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • CHINA
    • TABLE 53: China Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 55: China 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 57: China Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 58: China 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 59: China Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 60: China Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 61: China 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • EUROPE
    • Digital Dose Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Digital Dose Inhalers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for Digital Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2023 & 2030
    • TABLE 65: Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 66: Europe Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 67: Europe 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Europe Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 70: Europe 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 71: Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 72: Europe Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 73: Europe 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • FRANCE
    • TABLE 74: France Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 75: France Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 76: France 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 77: France Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 78: France Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 79: France 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 81: France Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 82: France 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • GERMANY
    • TABLE 83: Germany Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 84: Germany Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 85: Germany 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Germany Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 88: Germany 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 89: Germany Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 90: Germany Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 91: Germany 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • ITALY
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Italy Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 94: Italy 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 95: Italy Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 96: Italy Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 97: Italy 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 98: Italy Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 99: Italy Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 100: Italy 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • UNITED KINGDOM
    • TABLE 101: UK Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 102: UK Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 103: UK 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 105: UK Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 106: UK 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 107: UK Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 108: UK Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 109: UK 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • SPAIN
    • TABLE 110: Spain Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 111: Spain Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 112: Spain 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 113: Spain Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 114: Spain Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 115: Spain 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 116: Spain Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 117: Spain Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 118: Spain 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • RUSSIA
    • TABLE 119: Russia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 120: Russia Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 121: Russia 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 122: Russia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 123: Russia Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 124: Russia 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 125: Russia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 126: Russia Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 127: Russia 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • REST OF EUROPE
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 129: Rest of Europe Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 130: Rest of Europe 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 132: Rest of Europe Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 133: Rest of Europe 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 135: Rest of Europe Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 136: Rest of Europe 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • ASIA-PACIFIC
    • Digital Dose Inhalers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 138: Asia-Pacific Historic Review for Digital Dose Inhalers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 139: Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2023 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 142: Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 143: Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 144: Asia-Pacific Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 145: Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 146: Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 147: Asia-Pacific Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 148: Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • AUSTRALIA
    • TABLE 149: Australia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 150: Australia Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 151: Australia 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 152: Australia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 153: Australia Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 154: Australia 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 155: Australia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 156: Australia Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 157: Australia 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • INDIA
    • TABLE 158: India Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 159: India Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 160: India 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 161: India Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 162: India Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 163: India 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 164: India Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 165: India Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 166: India 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • SOUTH KOREA
    • TABLE 167: South Korea Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 168: South Korea Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 169: South Korea 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 170: South Korea Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 171: South Korea Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 172: South Korea 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 173: South Korea Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 174: South Korea Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 175: South Korea 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 176: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 177: Rest of Asia-Pacific Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 178: Rest of Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 179: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 180: Rest of Asia-Pacific Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 181: Rest of Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 182: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 183: Rest of Asia-Pacific Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 184: Rest of Asia-Pacific 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • LATIN AMERICA
    • TABLE 185: Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 186: Latin America Historic Review for Digital Dose Inhalers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 187: Latin America 16-Year Perspective for Digital Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2023 & 2030
    • TABLE 188: Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 189: Latin America Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 190: Latin America 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 191: Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 192: Latin America Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 193: Latin America 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 194: Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 195: Latin America Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 196: Latin America 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • ARGENTINA
    • TABLE 197: Argentina Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 198: Argentina Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 199: Argentina 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 200: Argentina Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 201: Argentina Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 202: Argentina 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 203: Argentina Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 204: Argentina Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 205: Argentina 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • BRAZIL
    • TABLE 206: Brazil Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 207: Brazil Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 208: Brazil 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 209: Brazil Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 210: Brazil Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 211: Brazil 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 212: Brazil Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 213: Brazil Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 214: Brazil 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • MEXICO
    • TABLE 215: Mexico Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 216: Mexico Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 217: Mexico 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 218: Mexico Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 219: Mexico Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 220: Mexico 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 221: Mexico Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 222: Mexico Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 223: Mexico 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • REST OF LATIN AMERICA
    • TABLE 224: Rest of Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 225: Rest of Latin America Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 226: Rest of Latin America 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 227: Rest of Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 228: Rest of Latin America Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 229: Rest of Latin America 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 230: Rest of Latin America Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 231: Rest of Latin America Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 232: Rest of Latin America 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • MIDDLE EAST
    • TABLE 233: Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2022 through 2030 and % CAGR
    • TABLE 234: Middle East Historic Review for Digital Dose Inhalers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 235: Middle East 16-Year Perspective for Digital Dose Inhalers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2023 & 2030
    • TABLE 236: Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 237: Middle East Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 238: Middle East 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 239: Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 240: Middle East Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 241: Middle East 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 242: Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 243: Middle East Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 244: Middle East 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • IRAN
    • TABLE 245: Iran Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 246: Iran Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 247: Iran 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 248: Iran Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 249: Iran Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 250: Iran 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 251: Iran Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 252: Iran Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 253: Iran 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • ISRAEL
    • TABLE 254: Israel Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 255: Israel Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 256: Israel 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 257: Israel Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 258: Israel Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 259: Israel 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 260: Israel Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 261: Israel Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 262: Israel 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • SAUDI ARABIA
    • TABLE 263: Saudi Arabia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 264: Saudi Arabia Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 265: Saudi Arabia 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 266: Saudi Arabia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 267: Saudi Arabia Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 268: Saudi Arabia 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 269: Saudi Arabia Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 270: Saudi Arabia Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 271: Saudi Arabia 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 272: UAE Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 273: UAE Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 274: UAE 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 275: UAE Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 276: UAE Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 277: UAE 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 278: UAE Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 279: UAE Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 280: UAE 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • REST OF MIDDLE EAST
    • TABLE 281: Rest of Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 282: Rest of Middle East Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 283: Rest of Middle East 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 284: Rest of Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 285: Rest of Middle East Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 286: Rest of Middle East 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 287: Rest of Middle East Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 288: Rest of Middle East Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 289: Rest of Middle East 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030
  • AFRICA
    • TABLE 290: Africa Recent Past, Current & Future Analysis for Digital Dose Inhalers by Product - Metered Dose and Dry Powder - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 291: Africa Historic Review for Digital Dose Inhalers by Product - Metered Dose and Dry Powder Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 292: Africa 16-Year Perspective for Digital Dose Inhalers by Product - Percentage Breakdown of Value Sales for Metered Dose and Dry Powder for the Years 2014, 2023 & 2030
    • TABLE 293: Africa Recent Past, Current & Future Analysis for Digital Dose Inhalers by Type - Branded and Generic - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 294: Africa Historic Review for Digital Dose Inhalers by Type - Branded and Generic Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 295: Africa 16-Year Perspective for Digital Dose Inhalers by Type - Percentage Breakdown of Value Sales for Branded and Generic for the Years 2014, 2023 & 2030
    • TABLE 296: Africa Recent Past, Current & Future Analysis for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2022 through 2030 and % CAGR
    • TABLE 297: Africa Historic Review for Digital Dose Inhalers by Application - Asthma, COPD and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2021 and % CAGR
    • TABLE 298: Africa 16-Year Perspective for Digital Dose Inhalers by Application - Percentage Breakdown of Value Sales for Asthma, COPD and Other Applications for the Years 2014, 2023 & 2030

IV. COMPETITION